Intersect Diagnostics Overview

  • Founded
  • 2019

  • Status
  • Private

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $75K

Intersect Diagnostics General Information


Developer of novel biomarker signatures intended to be used in precision therapeutics. The company's technology is used in design, optimization, validation and deployment of proprietary assays on new drug development instruments, enabling medical research institutes in advancing novel therapies toward regulatory approval.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 635 Kingsbridge Lane
  • Ridgewood, NJ 07450
  • United States
+1 (201) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Intersect Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Angel (individual) 24-Mar-2020 $75K 0000 Completed Generating Revenue
To view Intersect Diagnostics’s complete valuation and funding history, request access »

Intersect Diagnostics Executive Team (2)

Name Title Board Seat Contact Info
Boaz Kurtis MD Founder & Chief Executive Officer
Edward Sitar Chief Financial Officer
To view Intersect Diagnostics’s complete executive team members history, request access »